Basic Information
Isosceles Pharmaceuticals is a preclinical-stage biotechnology company dedicated to developing candidate products for the mitigation of acute pain during the perioperative period. Additionally, utilizing a novel parenteral drug delivery system, Isosceles Pharmaceuticals is also developing a proprietary platform for treating acute pain.
Isosceles Pharmaceuticals, Inc.
NorthCarolina,United States of America
less than 15 people
--
--
Enterprise Profile
Industrial Sector
Concept
Application Scenarios